Real-World Effectiveness, Adherence, and Persistence among Patients with T2DM Initiating Dulaglutide

被引：0
|
作者：
Mody, Reema
Grabner, Michael
Yu, Maria
Turner, Ralph
Kwan, Anita
York, Whitney
Lando, Laura Fernandez
机构：
来源：
DIABETES | 2017年 / 66卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1327-P
引用
收藏
页码：A355 / A355
页数：1
相关论文
共 50 条
  • [11] REAL-WORLD COMPARATIVE EFFECTIVENESS ANALYSIS OF PATIENTS INITIATING INJECTABLE TREATMENTS FOR TYPE 2 DIABETES MELLITUS (T2DM): PILOT DATA FROM THE INITIATOR STUDY
    Grabner, M.
    Wei, W.
    Raparla, S.
    Quimbo, R. A.
    Cziraky, M. J.
    Thayer, S. W.
    Brekke, L.
    Buysman, E.
    Crown, W.
    Hu, W.
    Cuddihy, R.
    VALUE IN HEALTH, 2012, 15 (07) : A494 - A494
  • [12] Renoprotective effects of dulaglutide in patients with T2DM and CKD
    Sorensen, Charlotte M.
    Holst, Jens J.
    NATURE REVIEWS NEPHROLOGY, 2018, 14 (11) : 659 - 660
  • [13] Renoprotective effects of dulaglutide in patients with T2DM and CKD
    Charlotte M. Sorensen
    Jens J. Holst
    Nature Reviews Nephrology, 2018, 14 : 659 - 660
  • [14] INTENSIFY: effectiveness of insulin degludec/liraglutide (IDegLira) in a real-world T2DM population in the UAE
    Al Awadi, F.
    Aly, H.
    Bashier, A.
    Benavente, J. Medina
    Dhanwal, D. Kumar
    Jallo, M.
    Singhal, S.
    Abusnana, S.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2022, 186
  • [15] REAL WORLD EFFECTIVENESS OF DULAGLUTIDE AMONG PATIENTS WITH TYPE 2 DIABETES
    Mody, R.
    Yu, M.
    Fernandez, L.
    Shui, A.
    Kallenbach, L.
    Slipski, L.
    de Oliveira, Piras C.
    VALUE IN HEALTH, 2017, 20 (05) : A164 - A164
  • [16] Real-World Effectiveness among Patients with Type 2 Diabetes (T2D) Initiating Tirzepatide (TZP)
    Mody, Reema
    Desai, Karishma
    Teng, Chia-Chen
    Reznor, Gally
    Stockbower, Grace
    Grabner, Michael
    Benneyworth, Brian D.
    DIABETES, 2024, 73
  • [17] Effects of Insulin Adherence and Delivery Device on Real World Outcomes Among Patients With Type 2 Diabetes Mellitus (T2DM)
    Ayyagari, Rajeev
    Wei, Wenhui
    Cheng, David
    Pan, Chunshen
    Wu, Eric Q.
    DIABETES, 2013, 62 : A327 - A327
  • [18] Real-World A1C Changes and Prescribing Provider Types among T2DM Patients Initiating Treatment with Once-Weekly (OW) Semaglutide
    Frazer, Monica S.
    Swift, Caroline
    Sargent, Andrew
    Leszko, Michael
    Buysman, Erin
    Alvarez, Sara B.
    Noone, Joshua
    Gamble, Cory L.
    DIABETES, 2022, 71
  • [19] Therapeutically Exchangeable? A Real-World Outcome Study of Switching between Basal Insulin Analogs among T2DM Patients
    Levin, Philip
    Wei, Wenhui
    Miao, Raymond
    Xie, Lin
    Ye, Fen
    Baser, Onur
    Gill, Jasvinder K.
    DIABETES, 2014, 63 : A234 - A234
  • [20] Real world assessment of effectiveness and safety of FDC of remogliflozin etabonate and Vildagliptin in T2DM patients
    Bhattacharyya, S.
    Katare, S.
    Khaladkar, K.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2022, 186
12345